Conversations on Mental Health: Sharmin Ghaznavi, MD, PhD, & The Center for the Neuroscience of Psychedelics
Mass General researchers are testing the psychedelic compound psilocybin as a therapeutic for treatment-resistant depression.
About Sharmin Ghaznavi, MD, PhD
Treats:
- Adult
Medical Education
- M.D.; Ph.D., Yale University School of Medicine
- Residency, Massachusetts General Hospital*
American Board Certifications
- Psychiatry, American Board of Psychiatry and Neurology
Accepted Insurance Plans
- Aetna Health Inc.
- Beech Street
- Blue Cross Blue Shield - Blue Care 65
- Blue Cross Blue Shield - Indemnity
- Blue Cross Blue Shield - Managed Care
- Blue Cross Blue Shield - Partners Plus
- BMC HealthNet Mass Health MCO/ACO
- Centene/Celticare
- Cigna Behavioral Health
- Commonwealth Care Alliance
- Great-West Healthcare (formally One Health Plan)
- Health Care Value Management (HCVM)
- Humana/Choice Care PPO
- MassHealth
- Medicare
- Medicare - ACD
- Medicare ACO - ACD
- Medicare ACO - PBO
- OSW - Maine
- OSW - New Hampshire
- OSW - Rhode Island
- Private Health Care Systems (PHCS)
- Senior Whole Health
- TriCare
- Tufts Health Plan
- Unicare
- United Behavioral Health
- United Behavioral Health - MGH
- Well Sense Pediatrics
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.